What is Exelixis's unrealized gains on investments?

Exelixis (EXEL) reported unrealized gains on investments of $1.77M in Q1 2026.

How has Exelixis's unrealized gains on investments changed year-over-year?

Exelixis's unrealized gains on investments decreased by 54.7% year-over-year, from $3.91M to $1.77M.

What is the long-term trend for Exelixis's unrealized gains on investments?

Over 5 years (2020 to 2025), Exelixis's unrealized gains on investments has grown at a -3.8% compound annual growth rate (CAGR), from $5.93M to $4.89M.

Exelixis EXEL Unrealized Gains on Investments

Unrealized Gains on Investments at other companies

Ionis PharmaceuticalsIONS

$1.11M-55.8%

Summit TherapeuticsSMMT

——

BridgeBio PharmaBBIO

——

Jazz PharmaceuticalsJAZZ

——

AmgenAMGN

——

Other financials

Income statement

See full

Revenue$610.8M+10.0%

Gross profit$590.9M+10.2%

Operating income$251.3M+34.5%

Net income$210.5M+31.9%

EPS (diluted)$0.79+43.6%

Balance sheet

See full

Cash & equivalents$226.2M+23.1%

Total debt$169.5M-9.4%

Total equity$1.9B-9.2%

Total assets$2.6B-8.6%

Cash flow

See full

Operating cash flow$251.8M+19.1%

CapEx$1.5M-48.9%

Free cash flow$250.3M+20.1%

Valuation

See full

Market cap$13.05B+10.1%

Enterprise value$12.99B+9.5%

P/E15.7×-2.8×

P/S5.5×+0.3×

Profitability

See full

Gross margin96.4%-0.3pp

Operating margin39.4%+6.3pp

Net margin35.1%+7.1pp

FCF margin38.6%+2.9pp

Returns & leverage

See full

Return on equity41%+10.8pp

Debt / equity0.1×0.0×

Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's unrealized gains on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exelixis's unrealized gains on investments?: Exelixis (EXEL) reported unrealized gains on investments of $1.77M in Q1 2026.
How has Exelixis's unrealized gains on investments changed year-over-year?: Exelixis's unrealized gains on investments decreased by 54.7% year-over-year, from $3.91M to $1.77M.
What is the long-term trend for Exelixis's unrealized gains on investments?: Over 5 years (2020 to 2025), Exelixis's unrealized gains on investments has grown at a -3.8% compound annual growth rate (CAGR), from $5.93M to $4.89M.